NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1,RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A EUROPEAN PHASE-II TRIAL
O. Sander et al., NEUTRALIZATION OF TNF BY LENERCEPT (TNFR55-IGG1,RO-45-2081) IN PATIENTS WITH RHEUMATOID-ARTHRITIS TREATED FOR 3 MONTHS - RESULTS OF A EUROPEAN PHASE-II TRIAL, Arthritis and rheumatism, 39(9), 1996, pp. 1288-1288